| 期 |
标题 |
文件 |
| 卷 93, 编号 11 (2021) |
Clinical portrait of a patient with COVID-19. The experience of a multidisciplinary clinic |
(Rus)
|
|
Baimakanova G., Khatkov I., Dudina G., Chegodar A., Rumyantsev K., Sviridov F., Osipova A., Danishevich A., Noskova K., Pinashina E., Orlova N., Slezinger V., Chernova M., Tovstyko K., Bodunova N.
|
| 卷 93, 编号 11 (2021) |
Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis |
(Rus)
|
|
Bogomolov P., Ivashkin V., Bueverov A., Maev I., Sagalova O., Sleptsova S., Yushuk N., Gusev D., Zhdanov K., Chulanov V.
|
| 卷 93, 编号 11 (2021) |
Results of immunoprophylaxis of HIV-infected patients with 13-valent conjugated pneumococcal vaccine |
(Rus)
|
|
Zhestkov A., Zolotov M., Lyamin A., Borisova O., Chernova O., Zheleznova E., Ismatullin D.
|
| 卷 93, 编号 11 (2021) |
Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020 |
(Rus)
|
|
Pshenichnaya N., Kareva E., Leneva I., Bulgakova V., Kravchenko I., Nikolaeva I., Grekova A., Ivanova A., Puzyreva L., Khasanova G., Orlova S., Tikhonova E., Petrov V., Malinin O., Kolaeva N., Volchkova E., Kanshina N., Chulanov V.
|
| 卷 93, 编号 11 (2021) |
Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19 |
(Rus)
|
|
Kruglova T., Fomina D., Poteshkina N., Frolova N., Beloglazova I., Mutovina Z., Samsonova I., Kovalevskaja E., Zagrebneva A., Serdotetckova S., Chernov A., Lysenko M.
|
| 卷 93, 编号 11 (2021) |
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic |
(Rus)
|
|
Zubkin M., Frolova N., Kim I., Ushakova A., Usatiuk S., Iskhakov R., Diakova E., Chervinko V., Volodina E., Tomilina N., Kryukov E.
|
| 卷 93, 编号 11 (2021) |
CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups |
(Rus)
|
|
Abdullaev S., Denisenko N., Mirzaev K., Shuev G., Sozaeva Z., Kachanova A., Mammaev S., Kasaeva E., Gafurov D., Grishina E., Sychev D.
|
| 卷 93, 编号 10 (2021) |
The first Russian multicenter non-interventional registry study to study the incidence of vitamin D deficiency and insufficiency in Russian Federation |
(Rus)
|
|
Suplotova L., Avdeeva V., Pigarova E., Rozhinskaya L., Karonova T., Troshina E.
|
| 卷 93, 编号 10 (2021) |
Advanced glycation end products and oxidative stress as a basis for metabolic abnormalities in patients with type 1 diabetes after successful simultaneous pancreas-kidney transplantation |
(Rus)
|
|
Larina I., Severina A., Maganeva I., Ainetdinova A., Eremkina A., Gavrilova A., Shamhalova M., Dmitriev I., Pinchuk A., Shestakova M.
|
| 卷 93, 编号 10 (2021) |
Polymorphic variants of glutathione reductase – new genetic markers of predisposition to type 2 diabetes mellitus |
(Rus)
|
|
Azarova I., Klyosova E., Polonikov A.
|
| 卷 93, 编号 10 (2021) |
Clinical and laboratory characteristics and results of treatment of patients with ACTH-producing neuroendocrine tumors of various localization |
(Rus)
|
|
Golounina O., Belaya Z., Rozhinskaya L., Marova E., Pikunov M., Khandaeva P., Arapova S., Dzeranova L., Kuznetsov N., Fadeev V., Melnichenko G., Dedov I.
|
| 卷 93, 编号 10 (2021) |
Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases |
(Rus)
|
|
Tanashyan M., Surkova E., Antonova K., Lagoda O., Naminov A., Berdnikovich E., Fedin P., Titkova I.
|
| 卷 93, 编号 10 (2021) |
Leptin and leptin receptor evaluation in atherosclerotic plaques in patients with type 2 diabetes mellitus |
(Rus)
|
|
Dimitrova D., Mikhailov I., Tokarev K., Michurova M., Gorbacheva A., Danilova N., Malkov P., Kalashnikov V.
|
| 卷 93, 编号 10 (2021) |
Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy |
(Rus)
|
|
Demidova T., Lobanova K., Perekhodov S., Antsiferov M., Oynotkinova O.
|
| 卷 93, 编号 10 (2021) |
Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day |
(Rus)
|
|
Sklyanik I., Shestakova M.
|
| 卷 93, 编号 9 (2021) |
Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2 |
(Rus)
|
|
Koshelskaya O., Kharitonova O., Kologrivova I., Suslova T., Margolis N., Tereshenkova E., Rybina A., Karpov R.
|
| 卷 93, 编号 9 (2021) |
Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy – REGATTA) |
(Rus)
|
|
Kropacheva E., Khakimova M., Krivosheeva E., Zemlyanskaya O., Panchenko E.
|
| 卷 93, 编号 9 (2021) |
Dynamics of Holter electrocardiogram monitoring in patients with chronic heart failure and atrial fibrillation on the background of cardiac contractility modulation |
(Rus)
|
|
Safiullina A., Uskach T., Sharapova Y., Kochetov A., Sapelnikov O., Tereshchenko S.
|
| 卷 93, 编号 9 (2021) |
Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation |
(Rus)
|
|
Dzaurova K., Mironov N., Yuricheva Y., Vlodzyanovsky V., Mironova N., Laiovich L., Malkina T., Zinchenko L., Sokolov S., Golitsyn S.
|
| 卷 93, 编号 9 (2021) |
Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry |
(Rus)
|
|
Valieva Z., Martynyuk T., Nakonechnikov S., Chazova I.
|
| 卷 93, 编号 9 (2021) |
Prognostic impact of uric acid in patients with acute decompensated heart failure |
(Rus)
|
|
Nasonova S., Lapteva A., Zhirov I., Mindzaev D., Tereshchenko S.
|
| 卷 93, 编号 8 (2021) |
Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic |
(Rus)
|
|
Ianushevich O., Maev I., Krikheli N., Levchenko O., Rogova I., Zaborovskii A., Andreev D., Kebina A., Bordin D., Bakulin I., Bakulina N., Andreev N., Asadulin P., Bagdasarian A., Devkota M., Evarnitskaia N., Krikunova O., Kucher S., Sokolov F., Fomenko A., Khar'kovskii V., Sharina I.
|
| 卷 93, 编号 8 (2021) |
Clinical and pharmacological approaches to the choice of a drug for a tension-type headache relief |
(Rus)
|
|
Shikh E., Khaytovich E., Perkov A.
|
| 卷 93, 编号 8 (2021) |
Osteosarcopenia in chronic pancreatitis |
(Rus)
|
|
Kozlova I., Bykova A.
|
| 卷 93, 编号 8 (2021) |
Risk factors for pancreatitis and pancreatic cancer |
(Rus)
|
|
Grigor’eva I., Efimova O.
|
| 卷 93, 编号 8 (2021) |
Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies |
(Rus)
|
|
Nosov A., Zenina M., Gorbushina O., Baidina A., Vlasova E., Alekseev V.
|
| 卷 93, 编号 8 (2021) |
Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome |
(Rus)
|
|
Pavlov A., Ivolgin A., Katenko S., Eremin M., Molodova A., Levchenko O., Karakozov A.
|
| 卷 93, 编号 8 (2021) |
Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study |
(Rus)
|
|
Andreev D., Maev I.
|
| 卷 93, 编号 8 (2021) |
The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial |
(Rus)
|
|
Demidova T., Krasil’nikova E., Vorob’ev S., Morugova T., Adasheva T.
|
| 卷 93, 编号 8 (2021) |
A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of Helicobacter pylori infection with the inclusion of the probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 |
(Rus)
|
|
Yakovenko E., Strokova T., Iakovenko A., Ivanov A., Soluyanova I., Vasilyev N.
|
| 卷 93, 编号 8 (2021) |
Gastroenterological symptoms in COVID-19 patients with mild severity of the disease: opportunities to optimize antidiarrheal therapy |
(Rus)
|
|
Ardatskaya M., Butorova L., Kalashnikova M., Nugaeva N., Ovchinnikov Y., Oynotkinova O., Pavlov A., Plavnik R., Sayutina E., Topchiy T., Trunova S.
|
| 卷 93, 编号 7 (2021) |
Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience |
(Rus)
|
|
Zherebtsova V., Vorobyev V., Gemdzhian E., Ulyanova M., Chernikov M., Ivanova V., Vinogradova O., Ptushkin V.
|
| 卷 93, 编号 7 (2021) |
Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma |
(Rus)
|
|
Firsova M., Mendeleeva L., Parovichnikova E., Solovev M., Kuzmina L., Risinskaya N., Abramova T., Galtseva I., Savchenko V.
|
| 卷 93, 编号 7 (2021) |
Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice |
(Rus)
|
|
Vorobyev V., Gemdzhian E., Fedorova L., Mikhailova N., Ilyasov R., Kaleikina L., Trubyakova O., Kaplanov K., Melnichenko E., Martynova E., Yakovleva E., Li O., Tarasenko E., Chumakova E., Bulieva N., Nesterova E., Margolin O., Zherebtsova V., Butaev L., Ptushkin V.
|
| 卷 93, 编号 7 (2021) |
Li–Fraumeni syndrome in adult patients with acute lymphoblastic leukemia |
(Rus)
|
|
Zarubina K., Parovichnikova E., Surin V., Pshenichnikova O., Gavrilina O., Isinova G., Troitskaya V., Sokolov A., Galtseva I., Kapranov N., Davydova J., Obukhova T., Nikulina E., Sudarikov A., Savchenko V.
|
| 卷 93, 编号 6 (2021) |
Clinical and laboratory signs and risk factors for nephrotoxicity, associated with antiangiogenic drugs |
(Rus)
|
|
Grechukhina K., Chebotareva N., Zhukova L., Krasnova T.
|
| 卷 93, 编号 6 (2021) |
Assessment of the influence of different factors on the risk of the development of a new coronavirus infection in patients with contrast induced acute kidney injury |
(Rus)
|
|
Isaev G., Mironova O., Fomin V.
|
| 卷 93, 编号 6 (2021) |
The analysis of secondary AA-amyloidosis current etiology and its influence on the approaches for diagnosis and treatment |
(Rus)
|
|
Rameev V., Kozlovskaya L., Rameeva A., Novikov A., Barsuk M.
|
| 卷 93, 编号 6 (2021) |
Effect of vitamin D receptor activators on serum Klotho levels in 3b–4 stages chronic кidney disease patients: a prospective randomized study |
(Rus)
|
|
Milovanova L., Beketov V., Milovanova S., Taranova M., Kozlov V., Pasechnik A., Reshetnikov V., Androsova T., Kalashnikov M.
|
| 卷 93, 编号 6 (2021) |
Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease |
(Rus)
|
|
Demyanova K., Kozlovskaya N., Korotchaeva Y., Apresyan S., Rylceva L., Usatenko G., Lugovoj A., Vorobyeva M., Bondarenko T., Bespalova A., Volkova O.
|
| 卷 93, 编号 6 (2021) |
The state of cytokine regulation and endothelial dysfunction in the combined course of vibration disease and arterial hypertension |
(Rus)
|
|
Babanov S., Baraeva R., Strizhakov L., Moiseev S., Fomin V.
|
| 卷 93, 编号 6 (2021) |
Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies |
(Rus)
|
|
Saganova E., Zubina I., Bogdanova E., Galkina O., Sipovskii V., Smirnov A.
|
| 卷 93, 编号 6 (2021) |
A novel approach to rapid induction of remission in primary membranous nephropathy |
(Rus)
|
|
Dobronravov V., Bystrova O., Kochoyan Z., Fomicheva E.
|
| 卷 93, 编号 6 (2021) |
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study |
(Rus)
|
|
Batyushin M.
|
| 卷 93, 编号 5 (2021) |
Soluble transferrin receptors and ferritin index in the diagnosis of iron deficiency in patients with spondyloarthritis and anemia |
(Rus)
|
|
Safarova K., Dorogoykina K., Fedotov E., Rebrov A.
|
| 卷 93, 编号 5 (2021) |
Evaluation of topical therapy of patients with osteoarthritis of small joints of the hands with Voltaren® Emulgel® 2% (diclofenac diethylamine 2%) |
(Rus)
|
|
Tsurko V., Gromova M.
|
| 卷 93, 编号 5 (2021) |
Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis |
(Rus)
|
|
Abramkin A., Lisitsyna T., Veltishchev D., Seravina O., Kovalevskaya O., Glukhova S., Nasonov E.
|
| 卷 93, 编号 5 (2021) |
Application of cardiovascular risk scales to identify carotid atherosclerosis in patients with rheumatoid arthritis |
(Rus)
|
|
Gerasimova E., Popkova T., Gerasimova D., Glukhova S., Nasonov E., Lila A.
|
| 卷 93, 编号 5 (2021) |
The prevalence of sarcopenia in patients with rheumatological pathology |
(Rus)
|
|
Lavrishcheva I., Jakovenko A., Rumyantsev A.
|
| 卷 93, 编号 5 (2021) |
The relationship between obesity, cardiometabolic disorders and disease activity in psoriatic arthritis patients: data from the Russian register |
(Rus)
|
|
Korsakova Y., Korotaeva T., Loginova E., Gubar E., Vasilenko E., Vasilenko A., Kuznetsova N., Patrikeeva I., Nasonov E.
|
| 351 - 400 的 550 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 11 > >>
|
